SEALSQ Highlighted Subsidiary Medical Tech Capabilities
The firm is positioning its IC'Alps unit to serve medical device developers needing custom integrated circuits.
Updated on Sept. 30, 2026 in Healthcare
Live Poll
Do you trust that modern medical devices are becoming safer due to advanced chip technology?
SEALSQ has moved to emphasize the medical technology capabilities of IC'Alps, a specialized subsidiary it acquired in August 2025. The move highlights the unit's work with device developers on integrated circuits designed for high-reliability medical environments.
Why it matters
Medical device developers are increasingly seeking specialized electronics to handle the complex requirements of miniaturization, data security, and long-term reliability in clinical settings. This strategic focus targets a growing segment of the healthcare hardware market.
The global medical electronics market was valued at $10.68 billion in 2025, with projections estimating growth to $16.73 billion by 2034. IC'Alps, which employs over 90 engineers, maintains operations in Grenoble and Toulouse, France.
The players
SEALSQ
A Geneva-based semiconductor company that focuses on secure hardware and integrated circuits.
IC'Alps
A subsidiary of SEALSQ that designs custom application-specific integrated circuits for the medical and industrial sectors.
The details
IC'Alps focuses on developing application-specific integrated circuits that must meet stringent international health standards. The unit adheres to ISO 13485 and ISO 14971 protocols, ensuring its designs satisfy the regulatory and safety requirements inherent in the medical device production cycle.
Timeline
IC'Alps began developing custom electronic solutions in 2018.
SEALSQ acquired the IC'Alps subsidiary in August 2025.
The medical electronics market reached a valuation of $10.68 billion in 2025.
IC'Alps is currently featured in the DeviceMed Buyer's Guide 2026-2027.
The medical electronics market is projected to reach $16.73 billion by 2034.
Market Landscape
The push reflects an ongoing industry trend where device manufacturers increasingly outsource specialized circuit design to firms with proven ISO 13485 compliance. This shift mirrors the broader transition toward high-security, miniaturized components required by the modern clinical market.
Developers and procurement managers should assess whether their hardware supply chain partners maintain ISO 13485 and ISO 14971 certification for new projects. Monitoring these design standards is critical for reducing long-term regulatory risk during the product approval process.
The takeaway
The medical electronics market requires a strict balance of specialized technical expertise and formal regulatory certification. Operators should verify that their design partners prioritize ISO 14971 risk management protocols to avoid potential delays in device certification.
Further reading
For additional context on industry trends, see our Healthcare section.
More information
Review company specifications and technical capabilities on the SEALSQ company website.
Live Poll
Do you trust that modern medical devices are becoming safer due to advanced chip technology?
